Hanall Biopharma financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩64.74B | ₩77.53B | ₩84.90B | ₩82.49B | ₩91.89B | ₩98.68B | ₩106.90B | ₩87.70B | ₩76.03B | ₩74.23B | ₩80.88B | ₩80.02B | ₩82.88B | ₩84.23B | ₩91.84B | ₩108.45B | ₩88.60B | ₩101.59B | ₩110.00B | ₩134.91B | ₩0.00M |
| GM % | Gross Margin % |
|
56.32% | 55.84% | 58.43% | 55.61% | 54.51% | 49.09% | 52.17% | 49.24% | 46.37% | 42.50% | 49.31% | 45.62% | 46.32% | 50.58% | 53.27% | 57.80% | 57.08% | 59.29% | 56.25% | 55.62% | 0.00% |
| OM | Operating Margin |
|
7.11% | 4.11% | 4.22% | -2.53% | 0.62% | 2.84% | 7.08% | -7.53% | -4.03% | -17.49% | 1.01% | -5.35% | 0.34% | 4.20% | 5.96% | 15.76% | 6.70% | 9.94% | 1.37% | 1.29% | 0.00% |
| EPS | Earnings Per Share |
|
₩-79.00 | ₩10.00 | ₩114.00 | ₩64.00 | ₩375.00 | ₩386.00 | ₩174.00 | ₩5.00 | ₩69.00 | ₩0.00 | |||||||||||
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
27.25m | 27.25m | 34.3m | 34.3m | 34.6m | 35.66m | 34.71m | 35.03m | 40.34m | 40.69m | 40.21m | 50m | 50.92m | 51.18m | 51.18m | 51.18m | 51.18m | 51.18m | 50.69m | 0m | 50.69m |
| OCF | Operating Cash Flow |
|
₩1.43B | ₩2.53B | ₩5.39B | ₩271.72M | ₩-3402.06M | ₩4.74B | ₩1.15B | ₩7.41B | ₩2.20B | ₩-7780.10M | ₩-3518.36M | ₩-454.02M | ₩3.95B | ₩42.14B | ₩-2994.39M | ₩20.49B | ₩929.29M | ₩839.87M | ₩25.20B | ₩29.64B | ₩0.00M |
| FCF | Free Cash Flow |
|
₩-373.46M | ₩368.04M | ₩3.52B | ₩-6440.32M | ₩-10575.44M | ₩-195.31M | ₩-2420.34M | ₩6.62B | ₩11.13M | ₩-12255.44M | ₩-4788.18M | ₩-2437.29M | ₩962.40M | ₩40.41B | ₩-4913.31M | ₩20.28B | ₩-1633.03M | ₩-3766.03M | ₩22.37B | ₩6.03B | ₩0.00M |
| FCFS | Free Cash Flow Per Share |
|
₩-41.31 | ₩4.82 | ₩87.02 | ₩-194.89 | ₩-409.24 | ₩-155.42 | ₩-321.50 | ₩16.58 | ₩-129.61 | ₩-352.95 | ₩-176.59 | ₩-81.68 | ₩-1.60 | ₩783.05 | ₩-96.01 | ₩238.68 | ₩-126.23 | ₩-159.41 | ₩344.92 | ₩403.32 | ₩0.00 |